Basic Information
Bugworks is a drug research and development company aimed at developing new drugs to combat antimicrobial resistance (AMR). Bugworks has proposed a new bacterial topoisomerase inhibitor (NBTI), which can effectively fight against a variety of drug-resistant bacterial pathogens.
Bugworks Research, Inc.
Bangalore,Karnataka,India
less than 15 people
February 04, 2014
info@bugworksresearch.com
Enterprise Profile
Industrial Sector
Concept
Application Scenarios